professor michael p lisanti, md-phd, frsa, frsb, frsc
School of Science, Engineering and Environment, University of Salford
Manchester, United Kingdom
Specialty Chief Editor
Cancer Metabolism
School of Science, Engineering and Environment, University of Salford
Manchester, United Kingdom
Specialty Chief Editor
Cancer Metabolism
University of New South Wales
Kensington, Australia
Specialty Chief Editor
Molecular and Cellular Oncology
Thomas Jefferson University
Philadelphia, United States
Specialty Chief Editor
Cancer Metabolism
Sant Joan de DĂ©u Hospital
Barcelona, Spain
Specialty Chief Editor
Pediatric Oncology
University of Texas MD Anderson Cancer Center
Houston, United States
Specialty Chief Editor
Breast Cancer
Faculty of Medicine and Health, The University of Sydney
Sydney, Australia
Specialty Chief Editor
Gastrointestinal Cancers: Colorectal Cancer
Department of Neuroscience, Catholic University of the Sacred Heart, Rome
Rome, Italy
Specialty Chief Editor
Cancer Genetics
The University of Manchester
Manchester, United Kingdom
Specialty Chief Editor
Surgical Oncology
Penn State Milton S. Hershey Medical Center
Hershey, United States
Specialty Chief Editor
Skin Cancer
University of Antwerp
Antwerp, Belgium
Specialty Chief Editor
Head and Neck Cancer
Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Specialty Chief Editor
Cancer Cell Signaling
Siena University Hospital
Siena, Italy
Associate Editor
Cancer Imaging and Image-directed Interventions
The University of Tokyo
Bunkyo, Japan
Associate Editor
Head and Neck Cancer
Cedars Sinai Medical Center
Los Angeles, United States
Associate Editor
Molecular and Cellular Oncology
Hospital Sirio Libanes
SĂŁo Paulo, Brazil
Associate Editor
Cancer Genetics